Biomarkers
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Commercial brain perfusion SPECT scan quantification databases offer efficiency but may yield different results than local databases. Specific brain regions like the Temporals and Precuneus show significant quantification differences, impacting disease threshold interpretation.
Area Of Science
- Neuroimaging
- Medical Physics
- Radiology
Background
- Accurate quantification of brain perfusion SPECT scans relies on control databases.
- Establishing local databases is time-consuming, necessitating efficient alternatives.
- Commercial databases offer a potential solution for centers lacking resources for local data collection.
Purpose Of The Study
- To investigate differences in brain region quantification using commercial versus local control databases for SPECT scans.
- To identify specific brain regions most affected by the choice of control database.
Main Methods
- Processed 35 SPECT scans using MIMNeuro software with both a local (31 controls) and a commercial (91 controls) database.
- Compared z-scores for key neurodegeneration-associated brain regions between the two databases.
- Utilized two-sample t-tests to assess region significance and applied thresholds (1.5 and 2.5 STDs) for disease severity.
Main Results
- Stronger correlation in quantification was observed on the right side of the brain compared to the left.
- Regions like the Temporals and Precuneus showed significant z-score differences (>20%) between databases, potentially altering disease classification.
- The Precuneus indicated higher disease levels with the commercial database, while the Temporals showed the opposite.
Conclusions
- The choice of control database (commercial vs. local) can significantly impact brain perfusion SPECT scan quantification and diagnostic interpretation.
- While local databases may offer greater population representation, commercial databases are a practical alternative for resource-limited centers.
- Further studies correlating with disease progression are needed to determine the most accurate quantification method.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...